Showing results (81-90 of 110) with videos related to
Sort By:
Pageof 11
Digestive Diseases and Sciences|March 3, 2017
Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort StudyMaria Kalafateli, Konstantinos Zisimopoulos, Georgia Vourli, et al.Annals of Gastroenterology|September 4, 2018
Clinical and epidemiological characteristics of hepatitis C virus-infected people who inject drugs: a Greek descriptive analysisHariklia Kranidioti, Christina Chatzievagelinou, Adonis Protopapas, et al.Annals of Gastroenterology|March 24, 2025
Treatment patterns and outcomes in hepatocellular carcinoma: Real-world experience in Greece from the retrospective OPAL studyJohn Koskinas, Spyridon Pantzios, Melanie Deutsch, et al.International Journal of Molecular Sciences|November 14, 2023
The Arising Role of Extracellular Vesicles in Cholangiocarcinoma: A Rundown of the Current Knowledge Regarding Diagnostic and Therapeutic ApproachesEleni-Myrto Trifylli, Anastasios G Kriebardis, Evangelos Koustas, et al.Journal of Viral Hepatitis|July 5, 2022
Significance of serum HBV RNA in non-cirrhotic HBeAg-negative chronic hepatitis B patients who discontinue effective antiviral therapyMargarita Papatheodoridi, Eleni Papachristou, Zissis Moschidis, et al.Journal of Viral Hepatitis|February 26, 2020
Randomized clinical trials towards a single-visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG-101 in chronic hepatitis C patients and long-acting injectable GSK2878175 in healthy participantsYanli Deng, Fiona Campbell, Kelong Han, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2021
Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort studyMargarita Papatheodoridi, Tung-Hung Su, Emilia Hadziyannis, et al.Frontiers in Medicine|March 21, 2022
Endotoxin Translocation and Gut Barrier Dysfunction Are Related to Variceal Bleeding in Patients With Liver CirrhosisChristos Triantos, Maria Kalafateli, Stelios F Assimakopoulos, et al.Journal of Viral Hepatitis|February 1, 2019
Immunological biomarkers as indicators for outcome after discontinuation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis BHariklia Kranidioti, Spilios Manolakopoulos, George Kontos, et al.Journal of Hepatology|September 9, 2014
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovirGeorge V Papatheodoridis, George N Dalekos, Cihan Yurdaydin, et al.Pageof 11